SJ,- Yes , FDA know Leronlimab , that was not needed imo ,
but this is only for 30 patients , others will need to be admitted with separate INDs ,

And I feel oncologists will ask for 700 mg as for M-i-L..( if I be a patient , I will ask for 700 mg )...
and hopefully if there are better results with 700 mg , FDA will see it..

And if results are close , then we all will learn something..


All IMO.